---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-080432"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-07-22T20:45:12+00:00"
generated_at: "2026-07-22T20:46:13.492987+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# 20/20 Biolabs enters standstill with Streeterville; receives Nasdaq bid price deficiency notice

## Summary
- Standstill agreement with Streeterville: 120-day forbearance on conversion of Series E preferred unless stock price >10% above Nasdaq Minimum Price.
- Nasdaq notified company of non-compliance with $1.00 bid price rule for 30 consecutive business days through July 16, 2026.
- Company has 180 calendar days (until January 13, 2027) to regain compliance by closing bid price at $1.00 for 10 consecutive business days.
- If not compliant by Jan 13, 2027, may qualify for a second 180-day period if it meets other listing standards.
- Company intends to monitor bid price and consider available options to cure the deficiency.

## SEC filing metadata
- accession: 0001213900-26-080432
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-07-22T20:45:12+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026080432/0001213900-26-080432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026080432/ea0298907-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-080432
- JSON: https://secwatch.observer/filing/0001213900-26-080432.json
- Plain text: https://secwatch.observer/filing/0001213900-26-080432.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.